Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care

Abstract

Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care. [Review]. Cochrane database of systematic reviews [online], Issue 11, article number CS011227.

The prescribing needs of community practitioner nurse prescribers: A qualitative investigation using the theoretical domains framework and COM‐B

“…Strengthening nurses’ capacity to include prescribing improves nurses’ ability to reach more people with quality health services (Weeks et al, ). Given the need to address health service demands in low‐, middle‐ and high‐income countries, our research should be of international interest.…”

“…Nurses are able to prescribe in several countries, including Ireland, Australia, Canada, New Zealand, Netherlands, Sweden, the USA and the UK (Ball, Barker, & Buchanan., J., ; Kroezen, Dijk, & Groenewegen, ; Weeks, George, & Maclure, ). Doctor shortages, the need to improve access to medicines, the development of advanced practitioner roles and a need to make better use of nurses’ skills, are each drivers for this role (Kroezen et al, ; Weeks et al, ).…”

Evaluating the impact of non-medical prescribing

“…The recent Cochrane Database systematic review by Weeks, Maclure and Stewart (2016) identified that non-medical prescribers were as effective as medical prescribers in achieving medication adherence, patient satisfaction and positive outcomes across a range of conditions. The current picture of NMP is identified in the 2015 report commissioned by Health Education North West (HENW): Non-Medical Prescribing (NMP): An Economic Evaluation.…”

The evolution of pharmacy practice research–Part I: Time to implement the evidence†

“…Similarly another Cochrane review focusing solely on hypertension concluded that ‘pharmacist led care may be a promising way of improving control in patients with hypertension, with the majority of RCTs being associated with improved blood pressure control, improved systolic blood pressure and more modestly improved diastolic blood pressure, but these interventions require further evaluation’ . Likewise, Santschi et al . showed an average reduction of 7.6/3.9 mmHg over 39 trials of pharmacist care versus usual care.…”